当前位置： SCI文献检索 > BMC CANCER期刊下所有文献 > Internet-based perioperative exercise program in patients with Barrett's carcinoma scheduled for esophagectomy [iPEP - study] a prospective randomized-controlled trial.

Internet-based perioperative exercise program in patients with Barrett's carcinoma scheduled for esophagectomy [iPEP - study] a prospective randomized-controlled trial.

Abstract：

BACKGROUND:Patients undergoing surgery for esophageal cancer have a high risk for postoperative deterioration of lung function and pulmonary complications. This is partly due to one-lung ventilation during thoracotomy. This often accounts for prolonged stay on intensive care units, delayed postoperative reconvalescence and reduced quality of life. Socioeconomic disadvantages can result from these problems. Physical preconditioning has become a crucial leverage to optimize fitness and lung function in patients scheduled for esophagectomy, in particular during the time period of neoadjuvant therapy. METHODS/STUDY DESIGN:We designed a prospective multicenter randomized-controlled trial. The objective is to evaluate the impact of an internet-based exercise program on postoperative respiratory parameters and pneumonia rates in patients with Barrett's carcinoma scheduled for esophagectomy. Patients are randomly assigned to either execute internet-based perioperative exercise program (iPEP), including daily endurance, resistance and ventilation training or treatment as usual (TAU). During neoadjuvant therapy and recovery, patients in the intervention group receive an individually designed intensive exercise program based on functional measurements at baseline. Personal feedback of the supervisor with customized training programs is provided in weekly intervals. DISCUSSION:This study will evaluate if an intensive individually adapted training program via online supervision during neoadjuvant therapy will improve cardiorespiratory fitness and reduce pulmonary complications following esophagectomy for Barrett's cancer. TRIAL REGISTRATION:NCT02478996 , registered 26 May 2015.

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Pfirrmann D,Tug S,Brosteanu O,Mehdorn M,Busse M,Grimminger PP,Lordick F,Glatz T,Hoeppner J,Lang H,Simon P,Gockel I

doi

10.1186/s12885-017-3400-8

subject

Has Abstract

pub_date

2017-06-14 00:00:00

pages

413

issue

1

issn

1471-2407

pii

10.1186/s12885-017-3400-8

journal_volume

17

pub_type

杂志文章,多中心研究,随机对照试验

相关文献

BMC CANCER文献大全
  • RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.

    abstract：BACKGROUND:RNA from exosomes and other microvesicles contain transcripts of tumour origin. In this study we sought to identify biomarkers of glioblastoma multiforme in microvesicle RNA from serum of affected patients. METHODS:Microvesicle RNA from serum from patients with de-novo primary glioblastoma multiforme (N = 9...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-12-22

    authors： Noerholm M,Balaj L,Limperg T,Salehi A,Zhu LD,Hochberg FH,Breakefield XO,Carter BS,Skog J

    更新日期：2012-01-17 00:00:00

  • A new score predicting the survival of patients with spinal cord compression from myeloma.

    abstract：BACKGROUND:This study was performed to create and validate a scoring system for the survival of patients with malignant spinal cord compression (SCC) from myeloma. METHODS:Of the entire cohort (N = 216), 108 patients were assigned to a test group and 108 patients to a validation group. In the test group, nine pre-trea...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-12-425

    authors： Douglas S,Schild SE,Rades D

    更新日期：2012-09-25 00:00:00

  • KAI1 suppresses HIF-1α and VEGF expression by blocking CDCP1-enhanced Src activation in prostate cancer.

    abstract：BACKGROUND:KAI1 was initially identified as a metastasis-suppressor gene in prostate cancer. It is a member of the tetraspan transmembrane superfamily (TM4SF) of membrane glycoproteins. As part of a tetraspanin-enriched microdomain (TEM), KAI1 inhibits tumor metastasis by negative regulation of Src. However, the underl...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-12-81

    authors： Park JJ,Jin YB,Lee YJ,Lee JS,Lee YS,Ko YG,Lee M

    更新日期：2012-03-06 00:00:00

  • Polymorphisms in miR-135a-2, miR-219-2 and miR-211 as well as their interaction with cooking oil fume exposure on the risk of lung cancer in Chinese nonsmoking females: a case-control study.

    abstract：BACKGROUND:The associations between microRNAs and lung cancer have received increasing attention. This study assess the association between polymorphisms in miR-135a-2, miR-219-2 and miR-211 genes and the risk of lung cancer, as well as the gene-environment interaction between these polymorphisms and cooking oil fume e...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-016-2784-1

    authors： Yin Z,Cui Z,Li H,Ren Y,Qian B,Rothman N,Lan Q,Zhou B

    更新日期：2016-09-23 00:00:00

  • Lentivirus-mediated CDglyTK gene-modified free flaps by intra-artery perfusion show targeted therapeutic efficacy in rat model of breast cancer.

    abstract：BACKGROUND:Free flap-mediated gene therapy in the tumor bed following surgical resection is a promising approach in cancer targeted treatment of residual disease. We investigated the selective killing efficacy of a lentivirus-mediated cytosine deaminase-thymidine kinase (CDglyTK) gene in transplanted breast cancer deli...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-019-6111-5

    authors： Zhang J,Liu Y,Zang M,Zhu S,Chen B,Li S,Xue B,Yan L

    更新日期：2019-09-14 00:00:00

  • Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer.

    abstract：BACKGROUND:Hyaluronan (HA) an important component of the extracellular matrix, has been linked to tumor progression and drug resistance in several malignancies. However, limited data is available for ovarian cancer. This study investigated the role of hyaluronan (HA) and a potential link between the HA-CD44 pathway and...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-13-476

    authors： Ricciardelli C,Ween MP,Lokman NA,Tan IA,Pyragius CE,Oehler MK

    更新日期：2013-10-14 00:00:00

  • The effect of neoadjuvant chemotherapy and chemoradiotherapy on exercise capacity and outcome following upper gastrointestinal cancer surgery: an observational cohort study.

    abstract：BACKGROUND:In 2014 approximately 21,200 patients were diagnosed with oesophageal and gastric cancer in England and Wales, of whom 37 % underwent planned curative treatments. Potentially curative surgical resection is associated with significant morbidity and mortality. For operable locally advanced disease, neoadjuvant...

    journal_title：BMC cancer

    pub_type： 临床试验,杂志文章,多中心研究

    doi：10.1186/s12885-016-2682-6

    authors： West MA,Loughney L,Ambler G,Dimitrov BD,Kelly JJ,Mythen MG,Sturgess R,Calverley PM,Kendrick A,Grocott MP,Jack S

    更新日期：2016-09-02 00:00:00

  • Resolution of severe hyponatraemia is associated with improved survival in patients with cancer.

    abstract：BACKGROUND:Hyponatraemia is a common finding in patients with cancer, and has been shown to be associated with poor prognosis in different settings. We have analysed the impact of severe hyponatraemia in patients with cancer. METHODS:A retrospective review of all patients admitted to a specialist cancer hospital with ...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-015-1156-6

    authors： Balachandran K,Okines A,Gunapala R,Morganstein D,Popat S

    更新日期：2015-03-22 00:00:00

  • Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer.

    abstract：BACKGROUND:First-line treatment with FOLFOXIRI plus bevacizumab (BEV) is highly effective and regarded as one of the standards-of-care for patients with metastatic colorectal cancer (mCRC), despite the high incidence of neutropenia and diarrhea as side effects. AXEPT, an Asian phase III study, showed that modified CAPI...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-020-07186-5

    authors： Miyo M,Kato T,Yoshino T,Yamanaka T,Bando H,Satake H,Yamazaki K,Taniguchi H,Oki E,Kotaka M,Oba K,Miyata Y,Muro K,Komatsu Y,Baba H,Tsuji A

    更新日期：2020-07-23 00:00:00

  • Genetic polymorphisms in the osteopontin promoter increases the risk of distance metastasis and death in Chinese patients with gastric cancer.

    abstract：BACKGROUND:In vitro and in vivo studies have suggested that osteopontin (OPN) is associated with many types of cancers. However, no studies have reported the incidence of OPN polymorphisms and the risk of gastric cancer. The aim of this study was to investigate the association between OPN polymorphisms and gastric canc...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-12-477

    authors： Zhao F,Chen X,Meng T,Hao B,Zhang Z,Zhang G

    更新日期：2012-10-16 00:00:00

  • Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control study.

    abstract：BACKGROUND:Whether chronic inflammation increases prostate cancer risk remains unclear. This study investigated whether chronic inflammatory diseases (CID) or anti-inflammatory medication use (AIM) were associated with prostate cancer risk. METHODS:Fifty-five thousand nine hundred thirty-seven cases (all prostate canc...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-019-5846-3

    authors： Beckmann K,Russell B,Josephs D,Garmo H,Haggstrom C,Holmberg L,Stattin P,Van Hemelrijck M,Adolfsson J

    更新日期：2019-06-21 00:00:00

  • Access to innovative drugs for metastatic lung cancer treatment in a French nationwide cohort: the TERRITOIRE study.

    abstract：BACKGROUND:Territorial differences in the access to innovative anticancer drugs have been reported from many countries. The objectives of this study were to evaluate access to innovative treatments for metastatic lung cancer in France, and to assess whether socioeconomic indicators were predictors of access at the leve...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-018-4958-5

    authors： Scherpereel A,Durand-Zaleski I,Cotté FE,Fernandes J,Debieuvre D,Blein C,Gaudin AF,Tournier C,Vainchtock A,Chauvin P,Souquet PJ,Westeel V,Chouaïd C

    更新日期：2018-10-22 00:00:00

  • Prognostic significance of helicobacter pylori-infection in gastric diffuse large B-cell lymphoma.

    abstract：BACKGROUND:Helicobacter pylori (H. pylori) is thought to have an oncogenic effect on the development of gastric malignancies. However, the effect of H. pylori status on the prognosis of gastric diffuse large B-cell lymphoma (DLBCL) remains unconfirmed. This study aimed to identify the prognostic importance of H. pylori...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-019-6067-5

    authors： Cheng Y,Xiao Y,Zhou R,Liao Y,Zhou J,Ma X

    更新日期：2019-08-28 00:00:00

  • Low levels of 3,3'-diindolylmethane activate estrogen receptor α and induce proliferation of breast cancer cells in the absence of estradiol.

    abstract：BACKGROUND:3,3'-diindolylmethane (DIM) is an acid-catalyzed dimer of idole-3-carbinol (I3C), a phytochemical found in cruciferous vegetables that include broccoli, Brussels sprouts and cabbage. DIM is an aryl hydrocarbon receptor (AhR) ligand and a potential anticancer agent, namely for the treatment of breast cancer. ...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-14-524

    authors： Marques M,Laflamme L,Benassou I,Cissokho C,Guillemette B,Gaudreau L

    更新日期：2014-07-21 00:00:00

  • Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients.

    abstract：BACKGROUND:The human leucine-rich, repeat-containing G protein-coupled receptor 5 (LGR5) is a stem cell marker in numerous adult tissues and is overexpressed in a large number of human carcinoma including colon cancer, breast cancer and oral squamous cell carcinomas (OSCC). The role of the full length transcript (LGR5F...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-019-5327-8

    authors： Rot S,Kaune T,Taubert H,Greither T,Kotrba J,Güttler A,Wichmann H,Bilkenroth U,Wienke A,Al-Nawas B,Bache M,Vordermark D,Wickenhauser C,Bethmann D,Eckert AW,Kappler M

    更新日期：2019-02-15 00:00:00

  • Targeting Id1 reduces proliferation and invasion in aggressive human salivary gland cancer cells.

    abstract：BACKGROUND:Salivary gland cancer (SGC) is one of the common malignancies of the head and neck area. It develops in the minor and major salivary glands and sometimes metastasizes to other organs, particularly to the lungs. Inhibitors of differentiation (Id) proteins are negative regulators of basic helix-loop-helix tran...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-13-141

    authors： Sumida T,Murase R,Onishi-Ishikawa A,McAllister SD,Hamakawa H,Desprez PY

    更新日期：2013-03-22 00:00:00

  • Systemic effect of catumaxomab in a patient with metastasized colorectal cancer: a case report.

    abstract：BACKGROUND:Catumaxomab, the first anti-EpCAM antibody, was approved in 2009 for the treatment of malignant ascites in cancer patients with EpCAM positive tumors. We consider this case of interest as treatment with catumaxomab not only prolonged the puncture-free interval but also showed a systemic effect in a patient w...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-13-618

    authors： Bezan A,Hohla F,Meissnitzer T,Greil R

    更新日期：2013-12-31 00:00:00

  • Case report of ascending colon cancer and multiple jejunal GISTs in a patient with neurofibromatosis type 1 (NF1).

    abstract：BACKGROUND:NF1(Neurofibromatosis type 1) is an autosomal dominant genetic disorder. Patients with NF1 have an increased risk of developing benign or malignant tumours, such as gastrointestinal stromal tumours (GISTs). However, the coexistence of NF1, GIST and colon cancer is very rare, and few cases have been reported ...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-019-6375-9

    authors： Shang L,Fang Z,Liu J,Du F,Jing H,Xu Y,Dong K,Zhang X,Wu H,Jing C,Li L

    更新日期：2019-12-05 00:00:00

  • Enhanced antitumor efficacy of cisplatin in combination with HemoHIM in tumor-bearing mice.

    abstract：BACKGROUND:Although cisplatin is one of the most effective chemotherapeutic agents, cisplatin alone does not achieve a satisfactory therapeutic outcome. Also cisplatin accumulation shows toxicity to normal tissues. In this study, we examined the possibility of HemoHIM both to enhance anticancer effect with cisplatin an...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-9-85

    authors： Park HR,Ju EJ,Jo SK,Jung U,Kim SH,Yee ST

    更新日期：2009-03-17 00:00:00

  • Clinical outcomes of HER2-positive metastatic breast cancer patients with brain metastasis treated with lapatinib and capecitabine: an open-label expanded access study in Korea.

    abstract：BACKGROUND:To evaluate efficacy in patients with brain metastasis (BM) on entry into the lapatinib expanded access program (LEAP). METHODS:LEAP is a worldwide, single-arm, open-label study. HER2-positive, locally-advanced or metastatic breast cancer patients with progression after an anthracycline, taxane, and trastuz...

    journal_title：BMC cancer

    pub_type： 临床试验,杂志文章,多中心研究

    doi：10.1186/1471-2407-12-322

    authors： Ro J,Park S,Kim S,Kim TY,Im YH,Rha SY,Chung JS,Moon H,Santillana S

    更新日期：2012-07-28 00:00:00

  • A phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPARC' trial protocol.

    abstract：BACKGROUND:Standard therapy for borderline-resectable pancreatic cancer in the UK is surgery with adjuvant chemotherapy, but rates of resection with clear margins are unsatisfactory and overall survival remains poor. Meta-analysis of single-arm studies shows the potential of neo-adjuvant chemo-radiotherapy but the rela...

    journal_title：BMC cancer

    pub_type： 杂志文章,多中心研究

    doi：10.1186/s12885-016-2765-4

    authors： Holyoake DL,Ward E,Grose D,McIntosh D,Sebag-Montefiore D,Radhakrishna G,Patel N,Silva M,Mukherjee S,Strauss VY,Odondi L,Fokas E,Melcher A,Hawkins MA

    更新日期：2016-09-13 00:00:00

  • Factors associated with late recurrence after completion of 5-year adjuvant tamoxifen in estrogen receptor positive breast cancer.

    abstract：BACKGROUND:Recent large trials have shown the survival benefits of 10-year use of tamoxifen by reducing late recurrence compared with 5-year therapy in estrogen receptor(ER)-positive breast cancer. We tried to identify clinical factors associated with the late recurrence. METHODS:We reviewed our database of ER-positiv...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-016-2423-x

    authors： Lee ES,Han W,Kim MK,Kim J,Yoo TK,Lee MH,Lee KH,Kim TY,Moon HG,Im SA,Noh DY,Lee ES

    更新日期：2016-07-07 00:00:00

  • A multicenter phase II study of everolimus in patients with progressive unresectable adenoid cystic carcinoma.

    abstract：BACKGROUND:The aim of this study was to examine the efficacy and safety of everolimus in patients with progressive unresectable adenoid cystic carcinoma (ACC). METHODS:Histologically confirmed ACC patients with documented disease progression within 12 months prior to the study entry were eligible. Everolimus was given...

    journal_title：BMC cancer

    pub_type： 杂志文章,多中心研究

    doi：10.1186/1471-2407-14-795

    authors： Kim DW,Oh DY,Shin SH,Kang JH,Cho BC,Chung JS,Kim H,Park KU,Kwon JH,Han JY,Kim MJ,Bang YJ

    更新日期：2014-11-03 00:00:00

  • An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma.

    abstract：BACKGROUND:The radiopharmaceutical (131)I-meta-iodobenzylguanidine ((131)I-MIBG) is an effective treatment for neuroblastoma. However, maximal therapeutic benefit from (131)I-MIBG is likely to be obtained by its combination with chemotherapy. We previously reported enhanced antitumour efficacy of (131)I-MIBG by inhibit...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-016-2656-8

    authors： Nile DL,Rae C,Hyndman IJ,Gaze MN,Mairs RJ

    更新日期：2016-08-11 00:00:00

  • A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy.

    abstract：BACKGROUND:This study aimed to evaluate the perioperative outcomes and prognostic impact of the consecutive steps of imaging, frailty assessment, and diagnostic laparoscopy (DLS) in patients with advanced epithelial ovarian cancer (EOC). METHODS:Patients diagnosed with EOC during 2012-2015 were analyzed retrospectivel...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-017-3476-1

    authors： Eoh KJ,Yoon JW,Lee JY,Nam EJ,Kim S,Kim SW,Kim YT

    更新日期：2017-07-12 00:00:00

  • Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis.

    abstract：BACKGROUND:Plasminogen activator inhibitor 1 (PAI-1) overexpression is an important prognostic and predictive biomarker in human breast cancer. SERBP1, a protein that is supposed to regulate the stability of PAI-1 mRNA, may play a role in gynaecological cancers as well, since upregulation of SERBP1 was described in ova...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-12-597

    authors： Serce NB,Boesl A,Klaman I,von Serényi S,Noetzel E,Press MF,Dimmler A,Hartmann A,Sehouli J,Knuechel R,Beckmann MW,Fasching PA,Dahl E

    更新日期：2012-12-13 00:00:00

  • Association of genetic polymorphisms CYP2A6*2 rs1801272 and CYP2A6*9 rs28399433 with tobacco-induced lung Cancer: case-control study in an Egyptian population.

    abstract：BACKGROUND:Several studies have reported the role of CYP2A6 genetic polymorphisms in smoking and lung cancer risk with some contradictory results in different populations. The purpose of the current study is to assess the contribution of the CYP2A6*2 rs1801272 and CYP2A6*9 rs28399433 gene polymorphisms and tobacco smok...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-018-4342-5

    authors： Ezzeldin N,El-Lebedy D,Darwish A,El Bastawisy A,Abd Elaziz SH,Hassan MM,Saad-Hussein A

    更新日期：2018-05-03 00:00:00

  • Aberrant allele-specific replication, independent of parental origin, in blood cells of cancer patients.

    abstract：BACKGROUND:Allelic counterparts of biallelically expressed genes display an epigenetic symmetry normally manifested by synchronous replication, different from genes subjected to monoallelic expression, which normally are characterized by an asynchronous mode of replication (well exemplified by the SNRPN imprinted locus...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-8-390

    authors： Dotan ZA,Dotan A,Ramon J,Avivi L

    更新日期：2008-12-25 00:00:00

  • The influence of radiotherapy techniques on the plan quality and on the risk of secondary tumors in patients with pituitary adenoma.

    abstract：BACKGROUND:This planning study compares different radiotherapy techniques for patients with pituitary adenoma, including flatness filter free mode (FFF), concerning plan quality and secondary malignancies for potentially young patients. The flatness filter has been described as main source of photon scatter. MATERIAL ...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-020-6535-y

    authors： Treutwein M,Steger F,Loeschel R,Koelbl O,Dobler B

    更新日期：2020-02-03 00:00:00

  • Chemotherapeutic agents attenuate CXCL12-mediated migration of colon cancer cells by selecting for CXCR4-negative cells and increasing peptidase CD26.

    abstract：BACKGROUND:Recurrence of colorectal cancer (CRC) may arise due to the persistence of drug-resistant and cancer-initiating cells that survive exposure to chemotherapy. Proteins responsible for this recurrence include the chemokine receptor CXCR4, which is known to enable CRC metastasis, as well as the cancer-initiating ...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-015-1702-2

    authors： Cutler MJ,Lowthers EL,Richard CL,Hajducek DM,Spagnuolo PA,Blay J

    更新日期：2015-11-10 00:00:00